Redox Report (Dec 2023)

Low intensity pulsed ultrasound ameliorates Adriamycin-induced chronic renal injury by inhibiting ferroptosis

  • Zhi-Qiang Ouyang,
  • Li-shi Shao,
  • Wei-peng Wang,
  • Teng-fei Ke,
  • Dong Chen,
  • Guang-rong Zheng,
  • Xi-rui Duan,
  • Ji-xiang Chu,
  • Yu Zhu,
  • Lu Yang,
  • Hai-yan Shan,
  • Lin Huang,
  • Cheng-de Liao

DOI
https://doi.org/10.1080/13510002.2023.2251237
Journal volume & issue
Vol. 28, no. 1

Abstract

Read online

ABSTRACTObjective It is very important to develop a new therapeutic strategy to cope with the increasing morbidity and mortality of chronic kidney disease (CKD). As a kind of physical therapy, low intensity pulsed ultrasound (LIPUS) has remarkable anti-inflammatory and repair-promoting effects and is expected to become a new therapeutic method for CKD. This study aims to clarify the treatment effect of LIPUS on CKD-related renal inflammation and fibrosis, and to further explore the potential signal network of LIPUS treatment for ameliorating chronic renal injury.Methods A rat model simulating the progress of CKD was established by twice tail-vein injection of Adriamycin (ADR). Under anesthesia, bilateral kidneys of CKD rats were continuously stimulated by LIPUS for four weeks. The parameters of LIPUS were 1.0 MHz, 60 mW/cm2, 50% duty cycle and 20 min/d.Results LIPUS treatment effectively inhibited ADR-induced renal inflammation and fibrosis, and improved CKD-related to oxidative stress and ferroptosis. In addition, the therapeutic effect of LIPUS is closely related to the regulation of TGF-β1/Smad and Nrf2/keap1/HO-1 signalling pathways.Discussion This study provides a new direction for further mechanism research and lays an important foundation for clinical trials.

Keywords